Navigation Links
Sean Hurley Joins Ameritox as Vice President for Insurance and Managed Care Contracting
Date:6/5/2009

BALTIMORE, June 5 /PRNewswire/ -- Ameritox, the U.S. leader in pain prescription monitoring, has announced the appointment of Sean Hurley as Vice President of Insurance and Managed Care Contracting. Hurley will oversee the company's contracting activities and support within the managed care market.

"We are thrilled to have Sean on board," said Ancelmo E. Lopes, CEO of Ameritox. "His appointment underscores our ongoing commitment to provide our payors with both data and tools to improve quality of care for their members with chronic pain."

Hurley's career spans more than two decades. From his service as a Captain in the U.S. Army, he began in healthcare at Abbott Laboratories as a hospital representative. There, he honed his skills for working with P&T Committees and quickly moved into managed care sales. For the next 18 years, he continued in progressively senior positions at leading organizations in the pharmaceutical, biotech and laboratory industries including Quest Diagnostics and Roche Laboratories.

During his tenure with Novo Nordisk (2001-2008), Hurley's success in sales growth and work with payors prompted three promotions in less than seven years. As Novo Nordisk's Associate VP of Managed Markets, Sean was instrumental in building a team that was ranked as one of the Top 3 organizations for the past five years, as reported by the Health Industry Research Center (HIRC).

Sean Hurley earned a bachelor's degree from St. Lawrence University and he is currently a Member of the Executive Planning Committee for the American Diabetes Association for Upstate New York. He will be based at Ameritox headquarters in Baltimore, MD.

About Ameritox

Ameritox is the nation's leader in pain prescription monitoring, processing thousands of specimens every day. Only Ameritox offers the Rx Guardian(SM) Report, the most thorough and personalized lab report available and the only report that uses a patented methodology to help physicians assess whether patients are taking their pain medication consistent with the dosage prescribed by their physicians. By comparing normalized values to expected prescription-specific ranges, Rx Guardian assists pain practitioners in protecting their patients by providing information to help them assess compliance based on prescription regimens. Rx Guardian also provides peace of mind to physicians and protection to their practices by providing data to help ensure that patients are taking pain medications as prescribed. Ameritox headquarters are located in Baltimore, MD, and its laboratory facilities are in Midland, TX. For additional information, please contact us by phone at 866-926-9264, by e-mail at information.request@ameritox.com, or visit http://www.ameritox.com.

AMERITOX, the AMERITOX logo, RX GUARDIAN and PROTECT YOUR PATIENTS, PROTECT YOUR PRACTICE are trademarks of Ameritox.

    Contact: Jennifer Paganelli
             Edelman
             212-642-7774
             jennifer.paganelli@edelman.com


'/>"/>
SOURCE Ameritox
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. iNutrition Signs John OHurley to Launch New Internet Video Campaign
2. AFSCME to Picket Hurley Medical Center, Flint
3. Hurley Medical Center Enhances Customer Service Capabilities With Beryl Partnership
4. Kendle Executive Dennis Hurley, DrSc to Present Keynote Address at DIA Latin American Congress 2007
5. Johns Hopkins University Applied Physics Lab Group Joins OrthoCare Innovations
6. Cognizant Joins Top Ten on Healthcare Informatics 100 List
7. Ryder System, Inc. Joins the American Red Cross Annual Disaster Giving Program
8. Former NIH Head Joins Mayo Clinic Trustees
9. Citi Private Equity Executive Joins Water Street Healthcare Partners
10. Pamela M. Arway Joins DaVita Board of Directors
11. Steven B. Epstein Joins Board of Management Health Solutions, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: